We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

49 hedge funds and large institutions have $374M invested in Epizyme, Inc in 2013 Q2 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+49
Holders Change %
–
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
49
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$170M +$155M +6,039,589 New
MAM
2
MPM Asset Management
Massachusetts
$81M +$74M +2,880,485 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$32.4M +$29.6M +1,150,483 New
PHS
4
PFM Health Sciences
California
$11.5M +$10.5M +408,608 New
Franklin Resources
5
Franklin Resources
California
$9.96M +$9.1M +354,100 New
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$9.14M +$8.35M +325,000 New
Primecap Management
7
Primecap Management
California
$6.76M +$6.18M +240,500 New
UBS AM
8
UBS AM
Illinois
$5.93M +$5.41M +210,648 New
Wellington Management Group
9
Wellington Management Group
Massachusetts
$5.8M +$5.3M +206,300 New
DCM
10
Driehaus Capital Management
Illinois
$5.74M +$5.24M +204,144 New
RCM
11
RA Capital Management
Massachusetts
$4.25M +$3.88M +151,000 New
BFA
12
BlackRock Fund Advisors
California
$3.77M +$3.44M +133,908 New
QF
13
QVT Financial
New York
$3.52M +$3.21M +125,000 New
EA
14
Emerald Advisers
Pennsylvania
$2.83M +$2.58M +100,569 New
BIT
15
BlackRock Institutional Trust
California
$2.55M +$2.33M +90,805 New
ICAP
16
Independence Capital Asset Partners
Colorado
$2.34M +$2.14M +83,335 New
Morgan Stanley
17
Morgan Stanley
New York
$2.09M +$1.91M +74,205 New
EMFAT
18
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.93M +$1.77M +68,719 New
State Street
19
State Street
Massachusetts
$1.65M +$1.5M +58,500 New
Principal Financial Group
20
Principal Financial Group
Iowa
$1.15M +$1.05M +41,000 New
VAM
21
Visium Asset Management
New York
$793K +$724K +28,166 New
Northern Trust
22
Northern Trust
Illinois
$724K +$661K +25,725 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$714K +$652K +25,375 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$662K +$605K +23,531 New
FSA
25
Franklin Street Advisors
North Carolina
$662K +$605K +23,550 New
1
2

EPZM Hedge Fund Activity: Q2 2013 in Review

49 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2013, worth a combined $374M.

Buyers outnumbered sellers: 49 funds opened new EPZM positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.

  • 49 institutional investors held Epizyme, Inc (EPZM) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $374M of Epizyme, Inc stock for Q2 2013.
  • 49 funds opened new Epizyme, Inc positions in Q2 2013 and 0 closed out, a net change of +49 holders.

Based on aggregated 13F filings for Q2 2013.